Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-10-09

Clinical Trial Update: The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating whether escitalopram can prevent depression and related emotional disorders in patients after acute stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lexapro (escitalopram)

Snippet

Sponsor: Asan Medical Center | Conditions: Depression | Phase 4 | Status: UNKNOWN